中华肾脏病杂志
中華腎髒病雜誌
중화신장병잡지
2013年
7期
498-502
,共5页
熊晓玲%叶有新%李华%冯剑%胡卫民%蒋欣欣%陆明晰%张树超
熊曉玲%葉有新%李華%馮劍%鬍衛民%蔣訢訢%陸明晰%張樹超
웅효령%협유신%리화%풍검%호위민%장흔흔%륙명석%장수초
血液透析%人造血管动静脉内瘘%狭窄%球囊扩张%覆膜支架
血液透析%人造血管動靜脈內瘺%狹窄%毬囊擴張%覆膜支架
혈액투석%인조혈관동정맥내루%협착%구낭확장%복막지가
Hemodialysis%Arteriovenous graft%Stenosis%Balloon angioplasty%Covered-stent
目的 探讨球囊扩张联合覆膜支架植入治疗人造血管动静脉内瘘(AVG)狭窄的临床疗效.方法 前瞻性选取15例经皮腔内血管成型术(PTA)疗效欠佳的AVG狭窄患者,且具备以下特点:狭窄长度不超过7 cm,狭窄程度大于50%;PTA后3个月内狭窄复发2次或以上;扩张后残余狭窄>30%或狭窄部位立即弹性回缩.所有患者在数字减影血管造影(DSA)下行球囊扩张后植入不同内径的聚四氟乙烯覆膜支架.结果 男3例,女12例,平均年龄(66±12)岁.支架植入前内瘘平均使用时间为(19.5±15.0)个月.共植入支架16枚,技术成功率100%,植入部位为静脉吻合口9例(9/15);静脉流出道6例(6/15),其中头静脉3例,肱静脉2例,腋静脉1例.首次开通率3个月为40%,6个月为19%,12个月为13%.再次开通率3个月为93%,6个月为88%,12个月为87%.术后平均随访时间为(14.9±5.3)个月,再窄狭率为87%(13/15).术后PTA 36例次,支架内狭窄36% (13/36);支架远端狭窄8% (3/36);支架近端狭窄22%(8/36);与支架无关的狭窄33% (12/36).AVG中位生存时间为25个月.结论 球囊扩张联合覆膜支架植入治疗AVG狭窄技术成功率高,并发症少,首次开通率不高,但再次开通率令人满意.
目的 探討毬囊擴張聯閤覆膜支架植入治療人造血管動靜脈內瘺(AVG)狹窄的臨床療效.方法 前瞻性選取15例經皮腔內血管成型術(PTA)療效欠佳的AVG狹窄患者,且具備以下特點:狹窄長度不超過7 cm,狹窄程度大于50%;PTA後3箇月內狹窄複髮2次或以上;擴張後殘餘狹窄>30%或狹窄部位立即彈性迴縮.所有患者在數字減影血管造影(DSA)下行毬囊擴張後植入不同內徑的聚四氟乙烯覆膜支架.結果 男3例,女12例,平均年齡(66±12)歲.支架植入前內瘺平均使用時間為(19.5±15.0)箇月.共植入支架16枚,技術成功率100%,植入部位為靜脈吻閤口9例(9/15);靜脈流齣道6例(6/15),其中頭靜脈3例,肱靜脈2例,腋靜脈1例.首次開通率3箇月為40%,6箇月為19%,12箇月為13%.再次開通率3箇月為93%,6箇月為88%,12箇月為87%.術後平均隨訪時間為(14.9±5.3)箇月,再窄狹率為87%(13/15).術後PTA 36例次,支架內狹窄36% (13/36);支架遠耑狹窄8% (3/36);支架近耑狹窄22%(8/36);與支架無關的狹窄33% (12/36).AVG中位生存時間為25箇月.結論 毬囊擴張聯閤覆膜支架植入治療AVG狹窄技術成功率高,併髮癥少,首次開通率不高,但再次開通率令人滿意.
목적 탐토구낭확장연합복막지가식입치료인조혈관동정맥내루(AVG)협착적림상료효.방법 전첨성선취15례경피강내혈관성형술(PTA)료효흠가적AVG협착환자,차구비이하특점:협착장도불초과7 cm,협착정도대우50%;PTA후3개월내협착복발2차혹이상;확장후잔여협착>30%혹협착부위립즉탄성회축.소유환자재수자감영혈관조영(DSA)하행구낭확장후식입불동내경적취사불을희복막지가.결과 남3례,녀12례,평균년령(66±12)세.지가식입전내루평균사용시간위(19.5±15.0)개월.공식입지가16매,기술성공솔100%,식입부위위정맥문합구9례(9/15);정맥류출도6례(6/15),기중두정맥3례,굉정맥2례,액정맥1례.수차개통솔3개월위40%,6개월위19%,12개월위13%.재차개통솔3개월위93%,6개월위88%,12개월위87%.술후평균수방시간위(14.9±5.3)개월,재착협솔위87%(13/15).술후PTA 36례차,지가내협착36% (13/36);지가원단협착8% (3/36);지가근단협착22%(8/36);여지가무관적협착33% (12/36).AVG중위생존시간위25개월.결론 구낭확장연합복막지가식입치료AVG협착기술성공솔고,병발증소,수차개통솔불고,단재차개통솔령인만의.
Objective To investigate the clinical effectiveness of balloon angioplasty with covered-stent placement for arteriovenous graft stenosis.Methods A total of 15 patients with arteriovenous graft stenosis which all had poor therapeutic effect by percutaneous transluminalangioplasty (PTA) were enrolled.All the patients had either one or more stenotic lesion,which had below features:7 cm or less in length and more stenosis (> 50%); stenosis recurred two or more times within 3 months after PTA; residual stenosis above 30% or elastic recoil immediately after expansion.Polytetrafluoroethylene-covered stents with different diameter were placed after balloon angioplasty by digital subtraction angiography (DSA).Results Patients were three men and twelve women with mean age (66±12) years.The mean duration of arteriovenous graft was (19.5±15.0) months at the time of stent insertion.Total 16 stents were placed.The technical success rate was 100%.Nine patients (9/15) were vein-graft anastomosis stenosis and 6 patients (6/15) were outflow stenosis with 3 at cephalic vein,2 at brachial vein and 1 at axillary vein.The primary access patency rates were 40% at 3 months,19% at 6 months and 13% at 12 months.The secondary access patency rates were 93% at 3 months,88% at 6 months and 87% at 12 months.The mean follow-up time was (14.9±5.3) months.The restenosis rate was 87%(13/15).PTA was done 36 times after stent placemen.The reasons for primary patency failure were in-stent stenosis 36% (13/36),inflow stenosis 8% (3/36),outflow stenosis 22% (8/36) and stenosis unrelated to stent placement 33% (12/36).The median survival time of AVG was 25 months.Conclusion Balloon angioplasty with covered-stent placement for arteriovenous graft stenosis has high rates of technical success and less complication.The primary access patency is low but secondary access patency is satisfied.